Positive Topline Results for Antihypertensive Zilebesiran 🔗 Access full article via Medscape NeurologyThe investigational siRNA therapeutic showed consistent and sustained reductions in systolic blood pressure in a phase 2 study of adults with hypertension. Medscape Medical News Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
